Dr. Ronald Glen Racho, DO

Dr. Racho practices at Jacksonville Center for Endoscopy - Southside in Jacksonville, Florida.

Dr. Racho's NPI, 1609133073, was assigned on April 23, 2012. Dr. Racho graduated from Texas College of Osteopathic Medicine in 2012. Dr. Racho holds Florida license OS12399.

Dr. Racho's primary practice is Jacksonville Center for Endoscopy - Southside, at 4800 Belfort Rd, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 265-4801.

Dr. Racho's primary practice is Jacksonville Center for Endoscopy - Southside in Jacksonville, Florida. Dr. Racho is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Borland Groover. Dmand AI also links Dr. Racho to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Racho practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Racho's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Racho is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Racho is licensed in Florida.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Racho treats.

CMS data shows 1,208 Medicare services from Dr. Racho across 14 procedure codes in 2024, for 480 Medicare patients. Medicare paid $90,528 for them.

CMS counts 480 Medicare patients who saw Dr. Racho in 2024. The largest group is 75 to 84, with 189 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Racho's median patient age at 61, with 54% women.

In 2024, Dr. Racho wrote 647 Medicare Part D claims for 167 patients. 83% of them were for generic drugs. CMS names the drug for 513 of them, across 16 drugs with 11 or more claims each, at $146,432 in total drug cost. In 2023, CMS named 367 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Racho for performance year 2024, reported as part of a group. Dr. Racho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 124 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Racho, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Racho, published from 2014 to 2017. 2014 was the busiest year, with 2. The most frequent topics are Adenoma, Colonic Neoplasms and Colonic Polyps. Dr. Racho's most frequent co-authors are Michael B. Wallace, MD, Murli Krishna, MD and Ernest P. Bouras, MD.

CMS Open Payments shows 304 general payments to Dr. Racho from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $2,001.

Dr. Racho graduated from Texas College of Osteopathic Medicine in 2012. Dr. Racho is a member of ACG, ACP, AGA, AMA, AOA and ASGE.

Dr. Racho is in network with 12 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.